Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560726 · ClinicalTrials.gov registry record · NA
Telehealth Cognitive Behavioral Stress Management for Adults With Cystic Fibrosis
A NA study, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03560726 is a NA study that has completed, run by National Jewish Health. The registered enrollment target is 31 participants.
The verdict
NCT03560726, a NA study, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study to to assess the feasibility, acceptability, and satisfaction of a telehealth cognitive behavioral stress management (CBSM) intervention among adults with cystic fibrosis (CF) who exhibit elevated anxiety and/or depression symptoms.
Interventions
- BEHAVIORAL Cognitive Behavioral Stress Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03560726
The ClinicalTrials.gov registry entry for NCT03560726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Stress Management is the first listed.
NCT03560726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03560726 about?
NCT03560726 is a clinical study titled "Telehealth Cognitive Behavioral Stress Management for Adults With Cystic Fibrosis". The purpose of this study to to assess the feasibility, acceptability, and satisfaction of a telehealth cognitive behavioral stress management (CBSM) intervention among adults with cystic fibrosis (CF) who exhibit elevated anxiety and/or depression symptoms.
What is the current status of trial NCT03560726?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2018-06-04. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03560726?
The interventions under investigation include: Cognitive Behavioral Stress Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03560726?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.